Which term refers to the lack of contaminants in a drug's active component?

• A. Discrepancies reporting
• B. Daily counting
• C. Bioavailability
• D. Purity

Answer: (D)

Purity is about how free the drug’s active component is from contaminants and unwanted substances. In pharmacology, the purity of the active pharmaceutical ingredient (API) is crucial because impurities can affect safety, efficacy, and stability. A highly pure API delivers a predictable dose and reduces the risk of adverse reactions caused by unidentified contaminants. Regulatory standards require specific purity levels and impurity profiles to be met before a drug can be approved and marketed.

Discrepancies reporting describes documenting deviations or issues, not the inherent quality of the API. Daily counting relates to inventory and supply management. Bioavailability concerns how much of the drug actually enters systemic circulation and becomes available to have an effect, not the presence or absence of contaminants.